Windtree Therapeutics Granted European Patent for Pure SERCA2a Activator, Potentially Advancing Heart Failure Treatment
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently announced a significant milestone, with the European Patent Office granting Patent No. 3805243. This patent provides composition of matter coverage for …
Windtree Therapeutics Granted European Patent for Pure SERCA2a Activator, Potentially Advancing Heart Failure Treatment Read More